Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by CytochromePon Aug 06, 2017 11:45am
73 Views
Post# 26552113

RE:RE:RE:RE:RE:Gel cap

RE:RE:RE:RE:RE:Gel capHe talks about it in his Leafcast interview.

Monteviale wrote:
I'm not sue which one of the three Vic was referring to, but if I had to specualte, could it be Accucaps Industry located in Windsor and Strathroy?  I remember Vic talking about the three possibilities in one of his presentations.  Does anyone remember the date or a link to the presentation?  

Accucaps has:

  • Two Plants
  • 500 workers between two sites
  • Previously owned by Apotex Inc.  Canada's largest pharmaceutical business with sales more than 1 billion a year and 7,500 workers worldwide
  • Accucaps Inc. was sold to Catalent Inc. in Novemeber 2016
  • Apotex said in a press release the deal “will substantially complement Catalent’s global OTC and prescription pharmaceutical softgel capabilities,” adding that Accucaps’ more than 500 employees in both facilities will be joining Catalent’s global network of 11 softgel technologies facilities.
Geographically and from a business decsion it makes sense.  Accucaps was taken over by Catelent in November 2016.  Catelent promotes themselves as the worlds #1 drug development, delivery and supply partner for drugs development.  

Catelant is a global provider of drug delivery technology and development solutions and operates 33 locations across five locations. , producing more than 70 billion doses annually for nearly 7,000 customer products.  

I'm curious if the takeover of Accucaps by Catelant was a strategic long term business decsion to line themselves up with a growing company "Aphria" in the the medical marijuana space?

Just thinking out loud.






Bullboard Posts